
Immunai
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
About
Immunai decodes the human immune system at unprecedented scale and resolution to facilitate the development of next-generation immune-related therapeutics. Their platform supports drug discovery and development by identifying novel targets, evaluating preclinical candidates, and optimizing clinical trials. They partner with biopharmaceutical companies and research institutions to provide actionable recommendations for advancing therapies.
Listed competitors
Also in this space
Develops a computational model of the human body for drug discovery and development.
Shares Healthcare, Drug Discovery
AI-driven drug discovery platform accelerating breakthrough scientific research.
Shares Healthcare, Drug Discovery
AI-powered spatial biology platform for precision medicine and drug development.
Shares Healthcare, HealthTech
Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.
Shares Healthcare, Genomics
Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.
Shares Healthcare, Genomics
AI-powered platform for profiling cancer biomarkers from digitized biopsy images.
Shares Healthcare, Genomics
Key facts
- Website
- immunai.com
- Headquarters
- New York, United States
- Founded
- 2019
- Employees
- 179
- Total funding
- $295M (Series B)
- Business model
- B2B
Funding rounds
Tech stack
Detected on immunai.com, last scanned 11 Aug 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Tag Manager
- SEO
- Rank Math
- CMS / Builders
- WordPress
- Email provider
- Google Workspace
- Cookie consent
- Cookiebot
Immunai scores 45. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Immunai trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Immunai is 83 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Immunai raised?
Immunai has raised a total of $295M in funding. The most recent round on record is Series B.
How many employees does Immunai have?
Immunai has approximately 179 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Immunai


